Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
913 INR | +0.25% | +3.21% | +0.26% |
05-22 | Eris Lifesciences Posts Gains in Fiscal Q4 Consolidated Net Profit | MT |
05-21 | Eris Lifesciences Gets Board Nod to Raise Up to INR12.50 Billion Via Bond Sale | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+39.22% | 731B | |
+32.46% | 586B | |
-7.85% | 348B | |
+15.48% | 319B | |
-0.12% | 273B | |
+13.53% | 235B | |
-7.08% | 203B | |
+7.38% | 202B | |
+2.93% | 159B |
- Stock Market
- Equities
- ERIS Stock
- ERIS Stock
- News Eris Lifesciences Limited
- Eris Lifesciences Board to Consider Interim Dividend for Fiscal 2023